Search details
1.
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
Br J Cancer
; 130(2): 224-232, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37973958
2.
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
Int J Clin Oncol
; 29(6): 764-770, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38555323
3.
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
Lancet Oncol
; 24(6): 624-635, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37269843
4.
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
Oncologist
; 28(11): e1108-e1113, 2023 Nov 02.
Article
in English
| MEDLINE | ID: mdl-37284901
5.
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
Int J Clin Oncol
; 28(3): 454-467, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36648710
6.
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Int J Clin Oncol
; 28(5): 644-653, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36899286
7.
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
Esophagus
; 20(3): 524-532, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36595124
8.
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer.
Int J Gynecol Cancer
; 2022 Apr 20.
Article
in English
| MEDLINE | ID: mdl-35444012
9.
Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
Invest New Drugs
; 37(4): 791-795, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30790150
10.
Common Sense Oncology: outcomes that matter.
Lancet Oncol
; 24(8): 833-835, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37467768
11.
[Measuring Financial Toxicity in Japanese Cancer Patients].
Gan To Kagaku Ryoho
; 45(5): 785-788, 2018 May.
Article
in Japanese
| MEDLINE | ID: mdl-30026437
12.
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
Invest New Drugs
; 35(2): 207-216, 2017 04.
Article
in English
| MEDLINE | ID: mdl-27928714
13.
A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.
Jpn J Clin Oncol
; 47(4): 298-305, 2017 Apr 01.
Article
in English
| MEDLINE | ID: mdl-28158463
14.
Should low-income countries invest in breast cancer screening?
Cancer Causes Control
; 27(11): 1341-1345, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27680017
15.
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(3): 641-51, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25809858
16.
Opioid-induced constipation.
Scand J Gastroenterol
; 50(11): 1331-8, 2015.
Article
in English
| MEDLINE | ID: mdl-26061717
17.
Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.
Cancers (Basel)
; 16(10)2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38791981
18.
Trifluridine/tipiracil with and without ramucirumab for advanced gastric cancer: a comparative observational study.
Sci Rep
; 14(1): 12658, 2024 06 03.
Article
in English
| MEDLINE | ID: mdl-38830895
19.
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
Ther Adv Med Oncol
; 16: 17588359241229428, 2024.
Article
in English
| MEDLINE | ID: mdl-38344409
20.
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study.
Anticancer Res
; 44(3): 1227-1232, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38423663